Global /South Korea /Healthcare /Drug Manufacturers - General /000020

Dongwha Pharm.Co.,Ltd

000020

• KRX: 000020 • Delayed

6,060KRW -0.5%

3.97 USD

As of 13 June 2026, Dongwha Pharm.Co.,Ltd has a market cap of $110.99M USD, ranking #24803 globally and #1158 in South Korea. It ranks #2214 in the Healthcare sector, and #800 in the Drug Manufacturers - General industry.

Global Rank

24803

Country Rank

1158

Sector Rank

2214

Industry Rank

800

Key Stats

Market Cap

$110.99MUSD

168.8B KRW

Enterprise Value

$189.72MUSD

289.54B KRW

Revenue (TTM)

$326.4MUSD

496.39B KRW

EBITDA (TTM)

$14.23MUSD

21.72B KRW

Net Income (TTM)

$5.71MUSD

8.69B KRW

EBITDA Margin

4.4%

Profit Margin

1.7%

PE Ratio

19.5

PS Ratio

0.3

PB Ratio

0.4

EV/EBITDA

13.3

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

826

Founded

1897

Website

dong-wha.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.5%	2%	1.2%	-0.3%	-4.4%	-2.6%	-1.8%	-27%	-61%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	000020 동화약품(주) ISIN: KR7000020008 Shares Out.: Shares Outstanding: 27.718M¹ Shares Float: 18.343M² TV: TradingView: KRX: 000020 SA: Stock Analysis: KRX: 000020 YF: Yahoo Finance: 000020.KS GF: Google Finance: KRX: 000020 BA: Barron's: 000020 MS: Morningstar: XKRX: 000020	6,060 KRW	TV: TradingView: KRX: 000020 SA: Stock Analysis: KRX: 000020 YF: Yahoo Finance: 000020.KS GF: Google Finance: KRX: 000020 BA: Barron's: 000020 MS: Morningstar: XKRX: 000020

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Dongwha Pharm.Co.,Ltd

Dongwha Pharm.Co.,Ltd manufactures and sells pharmaceutical products in South Korea. It offers ethical products in the areas of alimentary system, antibiotic, cardiovascular/metabolic disease, NSAID/respiratory system, muscle relaxants/musculoskeletal system, nervous system, and dermatological/urinary system; OTC products in the areas of alimentary system, cold remedy, NSAID/respiratory system, dermatological, mouth and tooth, hepatic protectors, nutrients, tonics, topic analgesic, antihistamines, sore throat, and others; quasi drugs; health subsidiary foods; foods and drinks; and cosmetics. The company also exports its products. Dongwha Pharm.Co.,Ltd was founded in 1897 and is headquartered in Seoul, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.15B 13.91T KRW 8K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.77B 10.3T KRW 6K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.24B 7.97T KRW 5K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.96B 7.55T KRW 4K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.55B 6.92T KRW 4K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.44B 6.76T KRW 4K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 686K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 493K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 325K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 290K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 260K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 247K%	20.5	Switzerland

chevron_leftBack